SCHEMBL31491032

SCHEMBL31491032

Fc1cc(I)c(Br)c2c(Cl)nc(Cl)nc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31491045 0.84 — —
SCHEMBL31490996 0.83 — —
SCHEMBL30539023 0.80 — —
SCHEMBL31412230 0.78 — —
SCHEMBL30099309 0.78 CYP11B1 (0.30) —
SCHEMBL31412213 0.74 MAPT (0.34) —
SCHEMBL29592633 0.73 — —
SCHEMBL26623643 0.73 — —
SCHEMBL21379233 0.73 — —
SCHEMBL30699586 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049274-A2 TETRACYCLIC DERIVATIVES, COMPOSITIONS AND METHODS THEREOF ENSEM THERAPEUTICS, INC. (US) 2025-03-06 — — WO disclosed
Send feedback